Table of Contents
What changed
Revenue rose 6.9% to NZ$126.5m and EBITDA rose 19.7% to NZ$14.6m, with management citing gross margins expanding from 22% to 26%. PBT grew 30.6% to NZ$9.7m, while reported NPAT jumped 65.1% to NZ$7.8m. The much larger cash movement sits below the P&L: operating cash flow swung to a NZ$26.0m inflow from an NZ$8.8m outflow in HY22, a NZ$34.9m turnaround. Cash rose to NZ$30.0m, gross borrowings fell from NZ$26.7m to NZ$17.2m, and the group moved from net debt of NZ$12.9m to net cash of NZ$12.8m. The interim dividend is held flat at 4.0 cps. Segment disclosure has changed from manufacturing-regional labels to a geographic cut, so like-for-like mix is not directly comparable; within the new cut the Americas (32.5%) and Europe (31.7%) dominate revenue, while New Zealand contributes ~19.5% of revenue but the lion's share of segment result.
What matters
- Tax, not operating leverage, drove the NPAT headline. The effective tax rate fell to 19.3% from 36.2%, opening a 34.6pp gap between PBT growth (30.6%) and NPAT growth (65.1%). PBT is the cleaner operating read.
- Balance sheet has materially strengthened. Net debt/EBITDA moved from roughly 1.1x to roughly –0.9x on an annualised basis, funded by the cash flow swing rather than by asset sales or an equity raise. This gives the group real optionality to fund the Scott 2025 strategy without refinancing stress.
- Margin expansion is the most important P&L signal. A 400bps gross margin lift despite inflation and supply-chain pressure, combined with 6.9% top-line growth, is what produced the PBT uplift. The durability of that margin, not the tax rate, is what will determine whether HY23 is a new baseline.
Expectations
No numeric guidance, no quantified forward-work or order-book figure, and no stated financial targets are disclosed in the extracted material, so any "run-rate" read is mechanical rather than management-endorsed. HY23 revenue annualises to NZ$253.1m, about 14.1% above FY22's NZ$221.8m, and HY23 EBITDA of NZ$14.6m already exceeds HY22's NZ$12.2m with a richer margin. The release flags a robust project pipeline qualitatively but does not quantify it, and no prior-year seasonality comment is given beyond the change in segment reporting; on that basis the release supports a "ahead of last year's run-rate" read but does not support a formal second-half expectation.
Quality of result
The operating result looks genuinely better: margins expanded, PBT grew at roughly 4x the rate of revenue, and the cash swing is large enough that it cannot be explained by timing alone. However, several quality caveats apply. First, the NPAT headline is tax-assisted — on a pre-tax basis growth is roughly half what the NPAT line suggests. Second, working capital intensity rose modestly (receivable days 48.8 → 51.5, inventory days 43.8 → 47.2, operating working-capital proxy up NZ$8.3m), so the cash flip reflects the unwind of an unusually weak HY22 (where operating cash flow was negative NZ$8.8m) more than a step-change in conversion. Third, EBITDA is disclosed without a full statutory reconciliation in the extracted material. Capex at 1.2% of revenue remains modest, leaving pre-lease free cash flow of NZ$24.5m (post-lease figure not derivable).
Unresolved
- How much of the gross margin lift from 22% to 26% is pricing, mix (e.g. richer services weighting), or productivity, and how much is sustainable into 2H?
- What drove the effective tax rate to 19.3%, and is that repeatable or a period-specific true-up?
- What is the quantified forward-work or order book underpinning the "robust pipeline" commentary?
- How does the new geographic segmentation reconcile to the prior manufacturing-regional cut, and which legacy segments are growing or contracting underneath it?
- Lease cash outflows, payables movement, and therefore true post-lease free cash flow and full working-capital dynamics are not disclosed in the extracted material.
This briefing cannot assess valuation, share-price implications, or management's internal financial targets, as none of those inputs are present in the extracted release.
Key metrics
| Metric | HY23 | HY22 | Change |
|---|---|---|---|
| Revenue | $126.5m | $118.4m | +6.9% ↑ |
| EBITDA | $14.6m | $12.2m | +19.7% ↑ |
| Net profit after tax | $7.8m | $4.7m | +65.1% ↑ |
| Net cash inflow from operating activities | $26.0m | −$8.8m | +394.4% ↑ |
| Interim dividend per share | 4.0c | 4.0c | flat |
| Profit before tax | $9.7m | $7.4m | +30.6% ↑ |
| Cash and cash equivalents | $30.0m | $13.7m | +117.9% ↑ |
| Total assets | $241.6m | $210.8m | +14.6% ↑ |
Reference: annolyse.ai/briefings/sct-hy23
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| New Zealand | $24.6m | — | $11.5m | n/a |
| Australia | $16.1m | — | $0.8m | n/a |
| Americas | $41.2m | — | $3.4m | n/a |
| Europe | $40.1m | — | $3.8m | n/a |
| China | $4.5m | — | $0.8m | n/a |
| Australasia Manufacturing | — | $62.1m | — | n/a |
| Americas Manufacturing | — | $18.2m | — | n/a |
| Europe Manufacturing | — | $30.5m | — | n/a |
| China Manufacturing | — | $7.6m | — | n/a |
Reference: annolyse.ai/briefings/sct-hy23
Analytical metrics
| Metric | HY23 | HY22 | Context |
|---|---|---|---|
| PBT growth | +30.6% | — | cleaner earnings measure |
| Effective tax rate | 19.3% | 36.2% | — |
| OCF / EBITDA (cash conversion) | 178.8% | -72.7% | stable |
| FCF pre-lease | $24.5m | −$10.0m | +$34.5m |
| FCF / NPAT | 312.4% | -211.3% | complementary conversion metric |
| Capex % revenue | 1.2% | 1.0% | — |
| Capex | −$1.6m | $1.2m | −$2.7m |
| Debtor days | 51.5 | 48.8 | +2.7 days |
| Inventory days | 47.2 | 43.8 | +3.4 days |
| Operating working capital | $68.6m | $60.3m | +$8.3m absorbed |
| Trade debtors | $35.8m | $31.8m | +$4.0m |
| Net debt | −$12.8m | $12.9m | −$25.7m |
| Net debt / EBITDA | -0.90x | 1.10x | Strengthening |
| Gross borrowings | $17.2m | $26.7m | −$9.5m |
| Payout ratio vs NPAT | 40.8% | — | — |
| ROE (annualised) | 7.4% | 4.5% | Strengthening |
| Profit from continuing operations | $7.8m | $4.7m | +$3.1m |
| Discontinued operation after tax | $0.0m | — | — |
Reference: annolyse.ai/briefings/sct-hy23
This analysis was generated using Annolyse, an AI-powered tool that extracts and analyses NZX company announcements. The underlying data is extracted from official company filings and verified against source documents. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.